Carbides to Molecules
Forthcoming · Germany
Source: EU Funding & Tenders Portal
Disubstituted carbon species, specifically carbenes (“CR2”) and their metal complexes, drive innovation across synthesis, catalysis, materials science, and medicine. In stark contrast, the corresponding carbynes (“CR”) and carbides (“C”) remain curiosity compounds or elusive entities. In fact, C1, C3 and to some extent C2 transfer generally remains a pressing challenge in the molecular sciences, w
- Status
- Prospective
- Sector
- Hospital, Commercial, Metal, Chemical (Industrial), Manufacturing (Industrial), Fertilizers, Government
- Location
- Germany
- Updated
- 19 Nov 2026
- Source
- EU Funding & Tenders Portal
ConstructChat
Ask ConstructChat about Carbides to Molecules
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | forthcoming |
Taiyo status | Prospective |
Taiyo last update | 2026-11-19 |
Contact
| Not available for this record. |
Description
Description | Disubstituted carbon species, specifically carbenes (“CR2”) and their metal complexes, drive innovation across synthesis, catalysis, materials science, and medicine. In stark contrast, the corresponding carbynes (“CR”) and carbides (“C”) remain curiosity compounds or elusive entities. In fact, C1, C3 and to some extent C2 transfer generally remains a pressing challenge in the molecular sciences, while the controlled synthesis of carbon allotropes represents a millenial challenge. CARB2MOL seeks to achieve this mission by introducing sustainable solid-state materials, namely abundant ionic carbides, as resources for molecules. Solubilized, and thus molecularized, aluminium, calcium and magnesium carbides will serve as long-sought general C1, C2 and C3 building blocks, enabling the synthesis of much-desired molecular inorganic and organic compounds. Specific elusive targets with relevance for synthesis, optoelectronics, and spintronics include super-reductants, carbon(0) allotropes, cumulenes with an odd number of carbon atoms, and nanoclusters. These metal clusters will provide a pioneering entry not only to carbon transfer catalysis but also nitrogen- and phosphorus functional group transfer. While interdisciplinary CARB2MOL relies on solid-state materials, its foundation lies in molecular coordination chemistry. It integrates concepts from organic- and main-group synthesis and leverages advanced spectroscopy as well as quantum chemical predictions. CARB2MOL uncovers vast chemical space by converting affordable and sustainable base chemicals into valuable molecules for high-end applications and even opens avenues to address the alchemists’ dream: Efficient, mild and bottom-up diamond synthesis. |
Location
Country | Germany |
Source
Source | EU Funding & Tenders Portal |
URL |
More Details
Record type | Project |
Sector | Hospital, Commercial, Metal, Chemical (Industrial), Manufacturing (Industrial), Fertilizers, Government |
Article published date | 2026-02-01 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Hospital projects in Germany
- Boehringer Ingelheim’s New Tablet Production Facility, Ingelheim
- Hameln Pharma Sterile Facility
- Takeda Pharmaceutical Manufacturing Facility, Oranienburg
- Merck Serono Biopharmaceutical R&D Facility Expansion, Darmstadt
- Evonik’s Pharmaceutical Lipids Manufacturing Facility, Hanau, Germany
- Wacker Chemie Biologics Production Facility
- Boehringer Ingelheim Biologicals Development Centre (BDC), Biberach, Germany
- Haupt Pharma, New Packaging Line
